drugset / Trial / NCT00308932

Effect of Age and Device on Delivery of Fluticasone

NCT00308932

Phase 4 Completed 60 enrolled University of Florida GlaxoSmithKline · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the effect of age and device on delivery of HFA-Fluticasone Propionate (FP) in children of different ages. Hypothesis -- passive inhalation in younger children through a valved holding chamber/mask (VHC) will reduce the relative amount of FP delivered to airways.

Timeline

Start
2003-02
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 110 ug Other

Indications